Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-05-25

Clinical Trial Update: Comparison of Oral Semaglutide w/ Placebo- Treatment for Latino Adults w/T2 Diabetes Receiving Enhanced Lifestyle Care [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing oral semaglutide with placebo plus enhanced lifestyle care in Latino adults with type 2 diabetes; the study status is terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • oral semaglutide (semaglutide)

Snippet

Sponsor: Sansum Diabetes Research Institute | Conditions: Diabetes Mellitus, Type 2, Glucose Metabolism Disorders (Including Diabetes Mellitus) | Phase 4 | Status: TERMINATED